Medicare Enrolled
Dr. Jennifer Symmank, MD
Family Medicine · Palestine, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Symmank from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Symmank?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Symmank
Dr. Jennifer Symmank is a family medicine specialist in Palestine, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Symmank performed 9,651 Medicare services across 5,097 unique beneficiaries.
Between the years covered by Open Payments, Dr. Symmank received a total of $15,049 from 62 pharmaceutical and/or device companies across 1072 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Symmank is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 1% volume in TX
$15,049 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,651
Medicare services
Top 1% in TX for family medicine
5,097
Unique beneficiaries
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~508 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Blood draw (venipuncture) | 1,107 | $8 | $10 |
| Comprehensive metabolic blood panel | 1,049 | $10 | $38 |
| Lipid panel (cholesterol and triglycerides) | 809 | $13 | $33 |
| Complete blood count (CBC) with differential | 805 | $8 | $28 |
| Office visit, established patient (30-39 min) | 798 | $81 | $190 |
| Thyroid stimulating hormone (TSH) test | 779 | $16 | $44 |
| Free thyroxine (T4) test | 774 | $9 | $26 |
| Hemoglobin A1c test (diabetes monitoring) | 429 | $10 | $27 |
| Chronic care management, first 20 min/month | 359 | $43 | $70 |
| Vitamin D level test | 172 | $29 | $75 |
| Office visit, established patient (20-29 min) | 170 | $54 | $135 |
| Annual wellness visit, follow-up | 167 | $124 | $160 |
| Electrocardiogram (EKG), 12-lead | 145 | $9 | $42 |
| Echocardiogram, transthoracic | 139 | $138 | $485 |
| Manual urinalysis test with examination using microscope, non-automated | 115 | $4 | $15 |
| Iron level test | 102 | $6 | $21 |
| Iron binding capacity test | 102 | $9 | $25 |
| Ferritin level test (iron stores) | 100 | $13 | $35 |
| 3D screening mammography (tomosynthesis) | 84 | $51 | $150 |
| Screening mammography | 83 | $122 | $230 |
| Bone density scan (DEXA) | 74 | $36 | $180 |
| Vitamin B-12 level test | 74 | $15 | $36 |
| Regadenoson injection (Lexiscan) for heart stress test | 73 | $45 | $78 |
| Steroid injection (triamcinolone) | 72 | $1 | $8 |
| Detection test by immunoassay with direct visual observation for influenza virus | 68 | $16 | $35 |
| Chest X-ray, 2 views | 64 | $24 | $48 |
| Dexamethasone injection (steroid) | 64 | $0 | $2 |
| Drug screening test | 59 | $61 | $100 |
| Flu vaccine administration | 53 | $30 | $35 |
| Flu vaccine, quadrivalent | 52 | $76 | $100 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 50 | $41 | $75 |
| Urine microalbumin test (kidney screening) | 45 | $6 | $20 |
| Ultrasound of both sides of head and neck blood flow | 43 | $129 | $476 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 36 | $8 | $41 |
| Prostate cancer screening; prostate specific antigen test (psa) | 35 | $19 | $52 |
| Uric acid level test | 33 | $4 | $18 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 31 | $323 | $665 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 31 | $47 | $194 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 31 | $136 | $410 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 25 | $31 | $55 |
| Chronic care management, additional 20 min/month | 24 | $35 | $56 |
| X-ray of lower and sacral spine, 2-3 views | 23 | $25 | $60 |
| New patient office visit (30-44 min) | 23 | $66 | $170 |
| Limited ultrasound scan of abdomen | 19 | $52 | $300 |
| Pneumonia vaccine administration | 19 | $30 | $35 |
| Placement of skin electrodes and measurement of stimulated sites on arms and legs | 18 | $261 | $634 |
| PSA test (prostate cancer screening) | 17 | $18 | $52 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 17 | $100 | $150 |
| Transitional care management services for problem of high complexity | 17 | $211 | $300 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 16 | $4 | $16 |
| Foot X-ray, 3+ views | 15 | $26 | $65 |
| Heart rhythm recording, analysis, report, review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 15 | $188 | $700 |
| Mri scan of brain without contrast | 14 | $150 | $792 |
| X-ray of upper spine, 2-3 views | 14 | $24 | $74 |
| Shoulder X-ray, 2+ views | 14 | $23 | $61 |
| Hip X-ray, 2-3 views | 14 | $36 | $75 |
| X-ray of middle spine, 2 views | 13 | $21 | $67 |
| Mri scan of lower spinal canal without contrast | 12 | $152 | $769 |
| X-ray of abdomen, minimum of 3 views | 12 | $33 | $60 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 12 | $16 | $32 |
| X-ray of knee, 1-2 views | 11 | $24 | $50 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 11 | $283 | $591 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.4% high complexity
3.7% medium
94.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$15,049
Total received (2018-2024)
Avg $2,150/year across 7 years
Top 2% in TX for family medicine
62
Companies
1,072
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,049 (86.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,901 (12.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$100 (0.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$924
2023
$1,159
2022
$2,945
2021
$2,132
2020
$1,575
2019
$3,224
2018
$3,091
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$2,326
Biohaven Pharmaceutical Holding Company Ltd.
$1,901
Novo Nordisk Inc
$1,319
PFIZER INC.
$853
Novartis Pharmaceuticals Corporation
$784
AbbVie Inc.
$755
GlaxoSmithKline, LLC.
$727
Merck Sharp & Dohme Corporation
$715
AstraZeneca Pharmaceuticals LP
$681
Janssen Pharmaceuticals, Inc
$553
ABBVIE INC.
$352
Astellas Pharma US Inc
$303
Takeda Pharmaceuticals U.S.A., Inc.
$284
Merck Sharp & Dohme LLC
$281
Amarin Pharma Inc.
$239
Boehringer Ingelheim Pharmaceuticals, Inc.
$233
Bayer HealthCare Pharmaceuticals Inc.
$218
Lilly USA, LLC
$198
Allergan Inc.
$192
Ironshore Pharmaceuticals Inc.
$175
AbbVie, Inc.
$162
Genentech USA, Inc.
$142
Sunovion Pharmaceuticals Inc.
$140
Esperion Therapeutics, Inc.
$129
JAZZ PHARMACEUTICALS INC.
$115
Teva Pharmaceuticals USA, Inc.
$111
SANOFI-AVENTIS U.S. LLC
$103
Lundbeck LLC
$92
Sumitomo Pharma America, Inc.
$85
Biohaven Pharmaceuticals, Inc.
$62
Nevro Corp.
$61
Bayer Healthcare Pharmaceuticals Inc.
$58
Abbott Laboratories
$55
Corium, LLC
$49
Otsuka America Pharmaceutical, Inc.
$43
Daiichi Sankyo Inc.
$38
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$33
Jazz Pharmaceuticals Inc.
$32
Mylan Specialty L.P.
$31
Eisai Inc.
$30
Supernus Pharmaceuticals, Inc.
$29
VIVUS LLC
$27
Kowa Pharmaceuticals America, Inc.
$26
Allergan, Inc.
$26
MAYNE PHARMA COMMERCIAL LLC
$25
Sanofi Pasteur Inc.
$25
iRhythm Technologies, Inc.
$24
Bioventus LLC
$20
Horizon Therapeutics plc
$18
Antares Pharma, Inc.
$16
ASSERTIO THERAPEUTICS, Inc.
$16
Exact Sciences Corporation
$15
GRT US Holding, Inc.
$15
Boston Scientific Corporation
$14
Almatica Pharma LLC
$14
ITI, Inc.
$13
E.R. Squibb & Sons, L.L.C.
$13
IRONWOOD PHARMACEUTICALS, INC
$12
Lupin Inc.
$12
Nestle HealthCare Nutrition Inc.
$11
Nalpropion Pharmaceuticals, Inc.
$10
Vertiflex, Inc.
$9
Top 3 companies account for 36.9% of total payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · ANORO · ANORO ELLIPTA · ANTARA · Aimovig · Amitiza · Azstarys · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREZTRI · CAPLYTA · CHANTIX · CONTRAVE · CREON · Cologuard Collection Kit · Corlanor · Creon · Dayvigo · Durolane · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · Esbriet · FARXIGA · FLUZONE HIGH-DOSE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GEMTESA · INJECTAFER · INVOKANA · JANUMET XR · JANUVIA · JARDIANCE · Jornay PM 20mg capsules (Bottle of 100) · KRYSTEXXA · Kerendia · LEQVIO · LINZESS · LONHALA MAGNAIR · LYRICA · Linzess · Livalo · MOUNJARO · MYRBETRIQ · NAPRELAN · NEXLETOL · NEXLIZET · NUCALA · NURTEC ODT · Omnia · Otezla · Ozempic · PNEUMOVAX 23 · PRALUENT · PREMARIN ORALS · PREVNAR 20 · Prolia · QSYMIA · QULIPTA · QVAR · Qutenza · REXULTI · REZUM · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SPIRIVA · STEGLATRO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Saxenda · Senza · Superion ISS · Synthroid · TEPEZZA · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULICITY · Tresiba · Trintellix · UBRELVY · Uloric · Utibron · VIBERZI · VRAYLAR · VYEPTI · Vascepa · Victoza · Vyvanse · Wegovy · XARELTO · XIFAXAN · XYOSTED · XYREM · Xofluza · Xyrem · Yupelri · ZENPEP · ZIO XT Patch · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (87%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in TX.
Equivalent to $156 per 100 Medicare services performed
Geographic Context
Family medicine physicians within 10 mi
33
Per 100K population
57.1
County median income
$58,846
Nearest hospital
PALESTINE REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Symmank is a clinical cardiology specialist, with above-average Medicare volume (top 1% in TX), with low-engagement industry engagement in the top 2% of TX peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Symmank experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Symmank performed 1,107 blood draw (venipuncture) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Symmank receive payments from pharmaceutical companies?
Yes. Dr. Symmank received a total of $15,049 from 62 companies across 1,072 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Symmank's costs compare to other family medicine physicians in Palestine?
Dr. Symmank's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Symmank) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Palestine
Browse family medicine physicians in Palestine ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in TX
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in TX
Which TX family medicine physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Biohaven Pharmaceutical Holding Company Ltd. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceutical Holding Company Ltd.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology